Subsequent Events |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Subsequent Events [Abstract] | |
| Subsequent Events |
Note 16 - Subsequent Events
On June 4, 2026, the Company’s wholly-owned subsidiary, DNA Complete, Inc. (“DNA Complete”), entered into an agreement of sale of future receipts (the “Third 2026 Future Receipts Financing Agreement”) with Legendary Funding Group, LLC (“Legendary”), by which Legendary purchased from DNA Complete its future accounts and contract rights arising from the sale of goods or rendition of services to DNA Complete’s customers, equal to a specified percentage of future receipts. The purchase price was $60,000, which was paid to DNA Complete net of a $6,000 origination fee, resulting in net proceeds of $54,000. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|